PGPaul Gross

Paul Gross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Gross has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Benchmarking models of care delivery within Cerebral Palsy Research Network sites

    by Laurie Glader, Paul H. Gross, Models of Care Working Group, Nina Miller, Michael C. Kruer

    Aim: To describe and benchmark the structure and service components of multidisciplinary cerebral palsy (CP) programs in North America. Method: This was a cross‐sectional descriptive benchmarking study utilizing a convenience sample from North American member sites within the Cerebral Palsy Research Network. Structured presentations on care delivery with standardized extraction included: programmatic structure; clinical flow; data collection and program improvement; and service offerings. Site investigators confirmed accuracy of each center's extracted data. Free‐text responses provided further context. Frequencies of the various aspects of service provision were calculated. Results: Eleven sites participated. Service delivery frequency was identified as foundational (present universally), core (present at 8–10 participating sites), or specialty (present at seven or fewer sites). Universal services included tone and orthotic management, access to therapies and equipment, orthopedic surveillance and surgery, neurosurgical procedures, and gait analysis. Specialty services included transition, adult, mental health, and reproductive care. Interpretation: Based on representation in our cohort, we propose a checklist of foundational, core, and specialty features as benchmarks for individual CP programs. Although additional work is needed to assess widespread consensus, applicability, and utility, our findings provide a preliminary framework for standardizing service delivery for centers striving to provide comprehensive CP care.


  • Multicenter Improvement in Screening for Dystonia in Young People With Cerebral Palsy

    by Bhooma Rajagopalan Aravamuthan, Emma J. Lott, Esra Pehlivan, Keerthana Chintalapati, Deborah Grenard, Desiree Roge, Rose Gelineau-Morel, Dante Kyle, Christie Becu, Michael C. Kruer, et al.

    Dystonia is a common, debilitating, and often treatment-refractory motor symptom of cerebral palsy (CP), affecting 70%-80% of this population based on research assessments. However, routine clinical evaluation for dystonia in CP has failed to match these expected numbers. Addressing this diagnostic gap is a medical imperative because the presence of dystonia rules in or out certain treatments for motor symptoms in CP. Therefore, our objective was to optimize rates of clinical dystonia screening to improve rates of clinical dystonia diagnosis. Using the quality improvement (QI) infrastructure of the Cerebral Palsy Research Network (CPRN), we developed and implemented interventions to increase the documentation percentage of 5 features of dystonia in young people with CP, aged 3-21 years. This QI initiative was implemented by 7 physiatry and pediatric movement disorders physicians at 4 tertiary-care pediatric hospitals between October 10, 2021, and July 1, 2023. Using a prospective cohort study design, we collected visit data across all participating sites every 2 weeks and tracked our progress using control charts. We assessed 847 unique visits, mostly for established patients (719/847, 85%) who were 9.2 years old on average (95% CI 8.8-9.5). By April 10, 2022, the mean percentage of dystonia screening elements documented across all sites increased from 39% to 90% and the mean percentage of visits explicitly documenting the presence or absence of dystonia increased from 65% to 94%. By October 23, 2022, the percentage of visits diagnosing dystonia increased from 57% to 74%. These increases were all sustained through the end of the study period on July 1, 2023. Using a rigorous QI-driven process across 4 member sites of a North American learning health network (CPRN), we demonstrated that we could increase screening for dystonia and that this was associated with increased clinical dystonia diagnosis, matching expected research-based rates. We propose that similar screening should take place across all sites caring for people with CP.


  • Open Access

    Involving people with lived experience when setting cerebral palsy research priorities: A scoping review

    by Evonne Younan, Sarah McIntyre, Natasha Garrity, Tasneem Karim, Mark Wallace, Paul Gross, Shona Goldsmith

    Aim: To describe research priority‐setting activities for cerebral palsy (CP) that have been conducted worldwide involving people with lived experience, focusing on participant characteristics, methods employed, identified research priorities, and collaboration as research partners.Method: The JBI scoping review approach was followed. Six electronic databases and grey literature were searched for all publications up to February 2024. We extracted study and participant characteristics, methods, and research priorities. Priorities were then categorized into prevention and cure, quality of life and community engagement, and service provision and intervention.Results: Five studies from North America and Australia met the inclusion criteria. Participants with lived experience were most often parents/caregivers (n = 135, proportion 12–80%), with 54 (proportion 12–25%) people with CP participating in the priority‐setting exercises. The studies' methods were varied, with surveys and workshops being the most common. The most reported category of research priorities was optimal intervention. People with lived experience collaborated as research partners (e.g. in aspects of study development/analysis/reporting) in four studies.Interpretation: This review, the first to examine CP research priority‐setting efforts on a global scale, identified five activities conducted to date. The small overall number of participants with lived experience of CP, originating only from North America and Australia, highlights the need for increased representation to better reflect the diverse CP community worldwide. Future projects need to address these gaps, using rigorous methodologies, and continued collaboration with research partners to ensure their perspectives shape and enhance the research agenda.


  • Uncertainties Regarding Cerebral Palsy Diagnosis

    by Bhooma R. Aravamuthan, Darcy L. Fehlings, Iona Novak, Paul Gross, Noor Alyasiry, Ann H. Tilton, Michael I. Shevell, Michael C. Fahey, Michael C. Kruer

    We have established that physicians, including neurologists, variably diagnose cerebral palsy (CP) when using the most recent CP definition from 2006. We also know that child neurologists and neurodevelopmentalists view themselves to be optimally suited to diagnose CP based on their training backgrounds. Therefore, to reduce variability in CP diagnosis, our objective was to elucidate uncertainties child neurologists and neurodevelopmentalists may have regarding practical application of the 2006 definition. We conducted a cross-sectional survey of child neurologists and neurodevelopmentalists built into a discussion seminar at the 2022 Child Neurology Society (CNS) Annual Meeting, the largest professional meeting of these specialists in North America. Seminar attendees were provided the 2006 definition and asked whether they had any uncertainties about the practical application of the definition across 4 hypothetical clinical vignettes. A group of national and international CP leaders then processed these data through iterative discussions to develop recommendations for clarifying the 2006 definition. The seminar was attended by 50% of all conference attendees claiming CME (202/401). Of the 164 closing survey respondents, 145 (88%) expressed uncertainty regarding the clinical application of the 2006 definition. These uncertainties focused on 1) age, both regarding the minimum and maximum ages of brain disturbance or motor symptom onset (67/164, 41%), and 2) interpretation of the term "nonprogressive" (48/164, 29%). Almost all respondents (157/164, 96%) felt that we should revise the 2006 consensus definition of CP. To address the most common CP diagnostic uncertainties we identified, we collectively propose 4 points of clarification to the 2006 definition: 1) motor symptoms/signs should be present by 2 years old; 2) CP can and should be diagnosed as early as possible; 3) the clinical motor disability phenotype should be nonprogressive through 5 years old; and 4) a CP diagnosis should be re-evaluated if motor disability is progressive or absent by 5 years old. We anticipate that clarifying the 2006 definition of CP in this manner could address the uncertainties we identified among child neurologists and neurodevelopmentalists and reduce the diagnostic variability that currently exists.


  • Cerebral palsy research network community registry adult surveys on function & pain: Successes, challenges, and future directions

    by Mary E. Gannotti, Paul H. Gross, Deborah E. Thorpe, Edward A. Hurvitz, Garey H. Noritz, Susan D. Horn, Michael E. Msall, Henry G. Chambers, Linda E. Krach, Cristina A. Sarmiento


  • Open Access

    Development and validation of a stakeholder-driven, self-contained electronic informed consent platform for trio-based genomic research studies

    by Bethany Y Norton, James Liu, Sara A Lewis, Helen Magee, Tyler N Kruer, Rachael Dinh, Somayeh Bakhtiari, Sandra H. Nordlie, Sheetal Shetty, Jennifer Heim, et al.

    Increasingly long and complex informed consents have yielded studies demonstrating comparatively low participant comprehension and satisfaction with traditional face-to-face approaches. In parallel, interest in electronic consents for clinical and research genomics has steadily increased, yet limited data are available for trio-based genomic discovery studies. We describe the design, development, implementation, and validation of an electronic iConsent application for trio-based genomic research deployed to support genomic studies of cerebral palsy. iConsent development incorporated stakeholder perspectives including researchers, patient advocates, institutional review board members, and genomic data-sharing considerations. The iConsent platform integrated principles derived from prior electronic consenting research and elements of multimedia learning theory. Participant comprehension was assessed in an interactive teachback format. The iConsent application achieved nine of ten proposed desiderata for effective patient-focused electronic consenting for genomic research. Overall, participants demonstrated high comprehension and retention of key human subjects’ considerations. Enrollees reported high levels of satisfaction with the iConsent, and we found that participant comprehension , iConsent clarity , privacy protections , and study goal explanations were associated with overall satisfaction . Although opportunities exist to optimize iConsent, we show that such an approach is feasible, can satisfy multiple stakeholder requirements, and can realize high participant satisfaction and comprehension while increasing study reach.


  • Adults with cerebral palsy and functional decline: A cross-sectional analysis of patient-reported outcomes from a novel North American registry

    by Mary E. Gannotti, Cristina A. Sarmiento, Paul H. Gross, Deborah E. Thorpe, Edward A. Hurvitz, Garey H. Noritz, Susan D. Horn, Michael E. Msall, Henry G. Chambers, Linda E. Krach


  • Adults with cerebral palsy and chronic pain experience: A cross-sectional analysis of patient-reported outcomes from a novel North American registry

    by Cristina A. Sarmiento, Mary E. Gannotti, Paul H. Gross, Deborah E. Thorpe, Edward A. Hurvitz, Garey H. Noritz, Susan D. Horn, Michael E. Msall, Henry G. Chambers, Linda E. Krach


  • A Mixed Methods Study of Practice Variation in Selective Dorsal Rhizotomy: A Study by the Cerebral Palsy Research Network

    by Ziyad Makoshi, Jeffrey Raskin, Robert Bollo, Brandon Rocque, Susan Zickmund, Patrick Galyean, Grace Perry, Samuel Browd, Paul Gross, Kristie Bjornson, et al.


  • Open Access

    Uncertainties regarding cerebral palsy diagnosis: opportunities to operationalize the consensus definition

    by Bhooma R Aravamuthan, Darcy L Fehlings, Iona Novak, Paul Gross, Noor Alyasiri, Ann Tilton, Michael Shevell, Michael Fahey, Michael Kruer

    Background and Objectives: Cerebral palsy (CP), the most common motor disability of childhood, is variably diagnosed. We hypothesized that child neurologists and neurodevelopmentalists, often on the frontlines of CP diagnosis in North America, harbor uncertainties regarding the practical application of the most recent CP consensus definition from 2006. Methods: We conducted a cross-sectional survey of child neurologists and neurodevelopmentalists at the 2022 Child Neurology Society Annual Meeting. Attendees were provided the 2006 CP consensus definition and asked whether they had any uncertainties about the practical application of the definition across four hypothetical clinical vignettes. Results: Of 230 attendees, 164 responded to the closing survey questions (71%). 145/164 (88%) expressed at least one uncertainty regarding the clinical application of the 2006 definition. Overwhelmingly, these areas of uncertainty focused on: 1) Age, both with regards to the minimum age of diagnosis and the maximum age of brain disturbance or motor symptom onset, (67/164, 41%), and 2) Interpretation of the term “non-progressive” (48/164, 29%). The vast majority of respondents (157/164, 96%) answered ‘Yes’ to the question: Do you think we should revise the 2006 consensus definition of CP? Discussion: We propose that the uncertainties we identified could be addressed by operationalizing the 2006 consensus definition to support a more uniform CP diagnosis. To address the most common CP diagnostic uncertainties we identified, we propose 3 points of clarification based on the available literature: 1) Motor symptoms/signs should be present by 2 years old; 2) CP can and should be diagnosed as early as possible, even if activity limitation is not yet present, if motor symptoms/signs can be reasonably predicted to yield activity limitation (e.g. by using standardized examination instruments, Brain MRI, and a suggestive clinical history); and 3) The clinical motor disability phenotype should be non-progressive through 5 years old. We anticipate that operationalizing the 2006 definition of CP in this manner could clarify the uncertainties we identified among child neurologists and neurodevelopmentalists and reduce the diagnostic variability that currently exists.